Advancing Medical Science Through Stem Cell Innovation

Revolutionizing Ophthalmology & Neurology

Discover how The Healing Institute is leading the forefront of medical advancements with groundbreaking stem cell treatments designed to tackle complex ophthalmology and neurology conditions. 

surgeon operating

Welcome to a new era of hope and healing with stem cell treatments. If you’ve been told by your physician that there’s no treatment for your condition, or worse, that you should simply accept it, we’re here to tell you that there’s another way forward.

Introducing our groundbreaking clinical studies for stem cell treatments, offering a ray of hope for conditions that were once considered untreatable. We understand the frustration of being told that nothing can be done, and we’re here to challenge that notion.

In our studies, we’ve witnessed countless patients, just like you, experience remarkable improvements in their conditions. These are individuals who were once told to resign themselves to their disability, individuals who were told that research was ongoing but no treatment was available. Yet, they dared to participate in our studies, and the results have been nothing short of astounding.

Imagine a life where your condition no longer dictates your limitations. Imagine a future where hope replaces resignation. That future is within reach.

Don’t settle for outdated beliefs and false limitations. Join us in rewriting the narrative of what’s possible. Take the first step towards a brighter future by participating in our clinical studies today. Your journey to renewed health and vitality starts here.

Innovative Research and Clinical Studies

The Healing Institute is at the forefront of pioneering research in regenerative medicine. Our FDA compliant, patient-funded clinical studies are inspired by the latest advancements in the field, focusing on stem cell therapies that hold the potential to revolutionize the treatment of vision impairment.

The Healing Institute sponsors the Stem Cell Ophthalmology Treatment Study II (SCOTS 2) which is an Investigational Review Board (IRB) approved clinical trial listed on the NIH website at with statistically significant results for certain eye diseases.

Our commitment to cutting-edge research allows us to explore new possibilities for vision that previously had no other treatment options. Each clinical study we undertake is a step towards finding effective treatments that could significantly improve the lives of those suffering from vision loss. By participating in our research, patients are contributing to a larger community dedicated to groundbreaking discoveries in eye health.

Welcome to the Stem Cell Ophthalmology Treatment Study II (SCOTS 2), the world’s largest study utilizing autologous Bone Marrow Derived Stem Cells. As pioneers in this field, our research aims to revolutionize treatments for vision loss stemming from optic nerve or retinal diseases. With 15 articles published in medical and scientific journals, our dedication to rigorous research is unwavering.

So, how does the study work? If you’re suffering from vision loss due to one of the conditions we study, you may be eligible to participate. Our process begins with a thorough evaluation with our Clinical Study Physician to determine your suitability for the study. If you qualify, you’ll be guided through each step of the treatment journey by our experienced team.


Throughout the study, your safety and well-being are our top priorities, and we’re committed to providing you with the highest standard of care throughout the study duration.

Join us in our mission to advance medical knowledge and improve the lives of those affected by vision loss. Contact us today to learn more about participating in the SCOTS 2 study and take the first step towards a brighter future for your vision.

stem cell video for blindness
man with glasses

Stephen Levy, M.D.

Dr. Levy serves as CEO of MD Stem Cells, a leading provider of adult stem cell patient treatment for various diseases.  He serves as Chair and Study Director for ongoing clinical studies including the Stem Cell Ophthalmology Treatment Study II (SCOTS2) and the Neurologic Stem Cell Treatment study (NEST).  All use bone marrow derived stem cells, are Institutional Review Board approved, FDA compliant and registered with the United States National Institutes of Health on .

Dr. Levy’s interest in leading edge medical technology and advancing medical care is long standing. He developed the first robotic approach to refractive eye surgery in mid 1980s and was actively involved in exploring areas of translational research including nanotechnology for ophthalmic applications. He was the first surgeon to perform topical anesthetic cataract surgery in New York City and among the first to use small incision and foldable lenses. His contributions to medical education include the training of many residents and setting the standard for minimally invasive eye surgery at three ophthalmology residency programs.

Following a career in the practice of ophthalmology, Dr. Levy transitioned into life science and healthcare business development, focusing on early stage companies. He is President of the Acoma Group which provides business development services for biopharmaceutical, medical and healthcare companies globally including an emerging stem cell start-up.  He has taught Anatomy & Physiology at the college level, been an Advisory Board member consultant with Gerson-Lehrman, and CEO of an early stage neurotech company involving memory research and recovery .   He routinely reviews manuscript submissions for a number of medical and scientific publications and has authored multiple journal publications.

‘Our mission is to unlock new possibilities in medicine.’

physician profile

Jeffrey N. Weiss, M.D.

Dr. Jeffrey N. Weiss is President of The American College of Regenerative Medicine and performed the first retinal stem cell surgery in the world in 2010. He is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world; The Neurologic Stem Cell Treatment Study; The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study; and The Alzheimer’s, Cognitive Impairment and Autism Treatment Study.  The studies are Institutional Review Board (IRB) approved, registered with NIH and listed on

Jeffrey N. Weiss, M.D., is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. He entered college at 16 years of age, and medical school at age 19 on full scholarships. While in medical school he obtained a degree in Electrical Engineering, Magna Cum Laude with distinction, and graduated from Medical School, Summa Cum Laude, at 23 years of age.

Dr. Weiss is the author of more than 100 publications, including 25 books, holds more than 20 U.S. and foreign patents and has been a Reviewer for multiple scholarly journals.  He has served as a Visiting Professor, performed surgery, and lectured both nationally and internationally.  Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc., which have manufactured and sold Dr. Weiss’ inventions worldwide.

Dr. Weiss was the first to invent the equipment and develop the technique to safely perform retinal vessel cannulation. This surgery remains the only option for patients with severe stroke in the eye. He was also the first to report the use of hyperbaric oxygen treatment to successfully treat dry age-related macular degeneration and longer standing central retinal artery occlusions.

Ready to Take the Next Step in Your Healthcare Journey?

Interested in the Clinical Study?  Contact us today to discuss your medical needs or to schedule a consultation with our esteemed doctor.

What Our Patients Say

‘After years of struggling with vision impairment, the stem cell treatment at The Healing Institute has drastically improved my sight. I can’t thank the team enough!’

Jane Dover

‘The neurological care I received was top-notch. My mobility has improved significantly, and I feel like I have a new lease on life.’

Michael Smith

‘I was skeptical about new treatments, but the results have been miraculous. The staff’s dedication made all the difference.’

Emily Johnson

Get In Touch


Coral Ridge Medical & Professional Center
831 Coral Ridge Dr, Suite 821
Coral Springs, FL 33071